Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of therapies for micro-orphan applications. The company develops a prenatal, neonatal and pediatric drug for orphans to cure disorder in newborn infants in the intensive care unit (ICU).
You’re viewing a free company profile from the PitchBook Platform. To explore Advent Therapeutics’s full profile, request a free trial.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.